Brain Tumor Leads Doctors on Path to Business

SUPPLEMENTS: Co. Targets Brain Health

Anesthesiologist James Lee was thinking as a doctor and scientist, rather than a businessman, when he researched the combination of supplements that helped him recover from chemotherapy to treat a brain tumor.

Tease photo

Pfenex Raises $39.4 Million in Stock Offering

Net proceeds from Pfenex’s common stock offering amounted to $39.4 million, it was recently announced.

Biocom Appoints Four Board Members

San Diego-based trade group Biocom appointed four new board members. The new members, announced May 31, play major roles in the region’s life sciences ecosystem:

ResMed to Acquire HEALTHCAREfirst

San Diego-based ResMed will acquire HEALTHCAREfirst, which specializes in software for home health and hospice agencies.

Payne Back in Charge at Arcturus Therapeutics

Once-ousted CEO Joseph Payne is back leading Arcturus Therapeutics. Even he saw a return as a longshot.

New Chair, Board Member for California Life Sciences Association

The California Life Sciences Association has a new board member: Jared Watkin, the senior vice president of Diabetes Care at Abbott Laboratories.

Arcturus, Former CEO Reach Settlement

Former Arcturus CEO Joseph Payne appears to have prevailed in a fight for control of the company.

Biotechs Seek Reward Of Commercialization

PHARMA: Skipping Partnerships Can Build Profits and Skill Sets

Several San Diego biotechs — including Neurocrine and Arena Pharmaceuticals — are bucking the norm by handling drug commercialization themselves.

Tease photo

J. Craig Venter Retiring from Human Longevity

J. Craig Venter is retiring as the CEO of San Diego-based Human Longevity, Inc., about five months after reassuming the role.

Local Cos. Find Rich Vein to Tap in Blood Diagnostics

BIOTECH: From Cancer to Concussions, Efforts Change Cost, Course of Treatments

Banyan Biomarkers hit a milestone in February when its blood test for traumatic brain injuries won U.S. Food and Drug Administration approval.

Tease photo

ResMed Disputes Australia Tax Levy of $190.1M

FINANCE: Co. Doesn’t Expect Any Change to U.S. Tax Assessment

San Diego-based ResMed is challenging an Australian Taxation Office assessment saying the company owes $190.1 million.

Tease photo

Bloom Science, Focused on Epilepsy Treatments, Debuts

San Diego-based Bloom Science, which emerged May 24, is drawing upon gut bacteria to develop medicines.

Evofem Lists $39.9M Public Stock Offering

San Diego biotech Evofem Biosciences, which focuses on women’s sexual and reproductive health, announced a public stock offering on May 22.

AristaMD Hires Chief Strategy Officer

San Diego’s AristaMD has hired Adam Darkins, known for his work with the Department of Veterans Affairs, as the company's chief strategy officer.

Biotech Co. Finds Tijuana a Good Fit for Its Operations

DEVICES: Thermo Fisher Exec Finds Infrastructure And Talent for Expansion

Maritza Diaz oversees operations at Thermo Fisher Scientific’s office in Tijuana. She splits her time between that office and the company’s campus in Carlsbad, her hometown.

Tease photo